By Sabela Ojea

Teva Pharmaceutical Industries Ltd. said Friday that it has reached its third settlement agreement with an U.S. attorney general over price-fixing claims.

The Israeli pharmaceutical company has denied the claims.

Teva will pay $3.3 million to the state of Georgia. The state will dismiss all claims against the company and its affiliates once the transaction has been made, Teva said.

The company also agreed to keep focusing on its antitrust training and compliance efforts throughout the U.S., Teva said.

Teva previously signed settlement agreements with Mississippi and Louisiana, while continuing to deny the allegations.

"Teva is pleased to put these claims behind us, and we believe the modest settlement amount--in each of the three settlements to date--reflects our position on the allegations against us, which we continue to deny," it said.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

September 30, 2022 08:45 ET (12:45 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Teva Pharmaceutical Indu... Charts.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Teva Pharmaceutical Indu... Charts.